SAUDI ARABIA – Johnson & Johnson MedTech KSA (J&J MedTech KSA) has entered into a multi-year logistics service contract with Tamer Logistics, a third-party logistics (3PL) company. As a subsidiary…
Read MoreTag: Johnson & Johnson
Alcon to pay Johnson & Johnson US$199M to settle eye-surgery tech dispute
USA — Alcon Vision has agreed to pay Johnson & Johnson’s Surgical Vision Inc US$199 million to settle intellectual property disputes over laser eye-surgery devices. According to a press release,…
Read MoreJ&J’s MedTech India ties with Karkinos to upskill healthcare workforce in cancer care
INDIA – Johnson & Johnson MedTech India has teamed up with Karkinos Healthcare, an end-to-end oncology solutions platform, for consistent up-skilling initiatives of healthcare professionals in cancer care. Johnson &…
Read MoreRoche expands collaboration with Janssen to develop companion diagnostics
SWITZERLAND — Roche has expanded its collaboration with Janssen Biotech to develop companion diagnostics for targeted therapies for an undisclosed amount. New agreement expands activities to include a wide range…
Read MoreJ&J partners with Evotec on targeted immune-based cancer therapies
USA — Janssen Biotech, Inc., an arm of Johnson & Johnson (J&J), has signed a strategic partnership and license deal with Evotec, a German drug maker to develop first-in-class targeted…
Read MoreJ&J experimental HIV vaccine candidate fails in advanced trials
USA — Johnson & Johnson has announced that it was discontinuing a late-stage global trial of an HIV vaccine after it was discovered to be ineffective at preventing infections. The…
Read MoreJ&J’s CEO Joaquin Duato to take an additional role as chairman of board
USA — Johnson & Johnson’s board of directors has elected Chief Executive Officer Joaquin Duato to the additional role of chairman, beginning in January. Alex Gorsky, who will step down…
Read MoreJohnson & Johnson to acquire cardiovascular technology company Abiomed for US$16.6B
USA— Johnson & Johnson (J&J) has struck a deal to buy heart pump maker Abiomed Inc for US$16.6 billion in cash, as it looks to boost growth in its medical…
Read MoreAmref, J&J unite to train oncology nurses amidst ongoing COVID-19 pandemic
KENYA – Amref Health Africa, the largest health development non-governmental international organisation based in Africa, and Johnson & Johnson have partnered to build the capacity of nurses in oncology nursing…
Read MoreFDA approves J&J’s multiple myeloma drug targeting BCMA and CD3 Proteins
USA —The Food and Drug Administration (FDA) has approved Johnson & Johnson’s B-Cell Maturation Antigen-CD3 (BCMA-CD3)-directed bispecific therapy for treating multiple myeloma, giving patients with the incurable blood cancer another…
Read More